Injective (INJ) is currently trading at $3.20, reflecting a 24-hour decline of 4.78%. The daily price range has been minimal, with a high of $3.38 and a low matching the current price, indicating a lack of volatility and potential resistance around the $3.38 level.

Trading volume stands at approximately $40.87 million, which is 12.78% of the market cap, suggesting moderate interest in the asset. The hourly moving averages are all trending negatively, with the 8 SMA at $3.23 and a decline of 0.93%, indicating short-term bearish sentiment.

The 1-hour RSI is at 29, which signals that INJ is currently oversold in the short term, potentially paving the way for a corrective bounce. Conversely, the 7-day RSI at 55 indicates a neutral trend, supported by a recent positive price change of 5.68% over the last week, reflecting some resilience in the mid-term.

Longer-term perspectives reveal a 14-day price change of 13.51%, indicating a more bullish sentiment over that timeframe, which may attract buyers looking for potential upside. However, the 30-day price change of 4.64% illustrates that the asset is struggling to maintain momentum, as the overall trend remains sluggish.

Injective's all-time high is significantly higher at $52.62, creating a substantial gap that may attract speculative interest in the long run. However, the current technical indicators suggest caution, as the price is far below this high and shows signs of weakness in the immediate term.

Based on the current analysis, a Hold rating is advised. The oversold condition on the 1-hour RSI may offer short-term trading opportunities, but broader bearish signals on the hourly moving averages and recent price action suggest that entering new positions may carry risk.